Direct Oral Anticoagulant Inhibitors: Mode of Action, Clinical Aspects

Area of Science:

• Pharmacology
• Hematology
• Clinical Medicine

Background:

• Direct oral anticoagulants (DOACs) represent a significant advancement in anticoagulant therapy.
• They offer targeted inhibition of specific coagulation factors, improving upon traditional anticoagulants.

Purpose of the Study:

• To provide a comprehensive overview of DOACs, including their mechanisms, clinical applications, and management strategies.
• To offer practical guidance for clinicians on the effective use of DOACs across various patient populations and clinical scenarios.

Main Methods:

• Review of existing literature and clinical guidelines on DOACs.
• Synthesis of information regarding DOACs' pharmacology, pharmacokinetics, and pharmacodynamics.
• Analysis of clinical trial data and real-world evidence for DOAC efficacy and safety.

Main Results:

• DOACs selectively target thrombin or activated factor X (FXa), leading to effective anticoagulation.
• DOACs demonstrate improved safety profiles, predictable pharmacokinetics, and reduced monitoring requirements compared to older agents.
• Guidance is provided on indications, contraindications, dosing, perioperative management, reversal strategies, and use in special populations.

Conclusions:

• DOACs have revolutionized anticoagulation management, offering a safer and more convenient alternative.
• Effective application of DOACs requires understanding their specific properties and tailored management approaches for different patient groups.
• This overview equips clinicians with the necessary knowledge for optimal DOAC utilization in clinical practice.